MyMD Pharmaceuticals, Inc. (MYMD)
NASDAQ: MYMD · IEX Real-Time Price · USD
2.390
+0.040 (1.70%)
At close: Mar 28, 2024, 4:00 PM
2.700
+0.310 (12.97%)
After-hours: Mar 28, 2024, 6:16 PM EDT

MyMD Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2011
Net Income
-15.2-29.89-9.49-3.89-10.85-7.37-3.3-9.31-3.14-1.53
Upgrade
Depreciation & Amortization
000.020.070.230.250.290.30.350.35
Upgrade
Share-Based Compensation
0.3415.042.860.390.040.310.080.050.550
Upgrade
Other Operating Activities
2.59-4.661.940.352.071.73-1.243.83-1.64-1.56
Upgrade
Operating Cash Flow
-12.27-19.52-4.66-3.07-8.5-5.08-4.17-5.13-3.88-2.73
Upgrade
Capital Expenditures
0000.01-0.07-0.05-0.12-0.11-0.02-0.12
Upgrade
Acquisitions
01.3800000-0.0600
Upgrade
Change in Investments
6.9118.470-3.95-0.29-4.963.975.25-9.270.1
Upgrade
Other Investing Activities
-------0.0100.09
Upgrade
Investing Cash Flow
6.9119.850-3.94-0.36-5.013.845.08-9.290.07
Upgrade
Share Issuance / Repurchase
5.551.191.986.971.955.80013.851.6
Upgrade
Debt Issued / Paid
0-1.122.700000-0.310.31
Upgrade
Other Financing Activities
----7.164.66---0.020.23
Upgrade
Financing Cash Flow
5.550.074.686.979.1110.460013.522.13
Upgrade
Net Cash Flow
0.190.410.01-0.050.240.37-0.33-0.050.35-0.53
Upgrade
Free Cash Flow
-12.27-19.52-4.66-3.07-8.57-5.13-4.3-5.25-3.91-2.85
Upgrade
Free Cash Flow Margin
-----514.56%-153.07%-145.11%-248.00%-88.29%-79.74%
Upgrade
Free Cash Flow Per Share
-9.48-16.72-4.96-300.46-1056.01-6310.82-9114.77-11753.87-9488.77-20584.79
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).